The FDA authorized COVID booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure.
FDA authorizes booster dose of Pfizer COVID-19 vaccine for people 65 and older, high-risk workers
